EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Compared Efficacy of Tocilizumab versus Rituximab in the Treatment of Refractory Rheumatoid Arthritis: A Randomized Clinical Trial study

Arman Ahmadzadeh, Faraneh Farsad, Alireza Rahaei, Mohammad Mehdi Emam, Latif Gachkar, Elnaz Shafighi Shahri

Journal of Advances in Medical and Biomedical Research · 2025

DOI: 10.30699/jambr.33.157.149 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Advances in Medical and Biomedical Research, 2025. Verfasst von Arman Ahmadzadeh und 5 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ahmadzadeh, A., Farsad, F., Rahaei, A., Emam, M. M., Gachkar, L., & Shahri, E. S. (2025). Compared Efficacy of Tocilizumab versus Rituximab in the Treatment of Refractory Rheumatoid Arthritis: A Randomized Clinical Trial study. Journal of Advances in Medical and Biomedical Research. https://doi.org/10.30699/jambr.33.157.149

Vancouver

Ahmadzadeh A, Farsad F, Rahaei A, Emam MM, Gachkar L, Shahri ES. Compared Efficacy of Tocilizumab versus Rituximab in the Treatment of Refractory Rheumatoid Arthritis: A Randomized Clinical Trial study. Journal of Advances in Medical and Biomedical Research. 2025. doi:10.30699/jambr.33.157.149

BibTeX
@article{Ahmadzadeh2025,
  author = {Ahmadzadeh, Arman and Farsad, Faraneh and Rahaei, Alireza and Emam, Mohammad Mehdi and Gachkar, Latif and Shahri, Elnaz Shafighi},
  title = {Compared Efficacy of Tocilizumab versus Rituximab in the Treatment of Refractory Rheumatoid Arthritis: A Randomized Clinical Trial study},
  journal = {Journal of Advances in Medical and Biomedical Research},
  year = {2025},
  doi = {10.30699/jambr.33.157.149}
}
Kostenlos starten →